Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 9
2004 4
2005 12
2006 8
2007 3
2008 7
2009 10
2010 8
2011 15
2012 13
2013 11
2014 13
2015 8
2016 18
2017 19
2018 25
2019 19
2020 13
2021 8
2022 6
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
Ishikawa Y, Kawashima N, Atsuta Y, Sugiura I, Sawa M, Dobashi N, Yokoyama H, Doki N, Tomita A, Kiguchi T, Koh S, Kanamori H, Iriyama N, Kohno A, Moriuchi Y, Asada N, Hirano D, Togitani K, Sakura T, Hagihara M, Tomikawa T, Yokoyama Y, Asou N, Ohtake S, Matsumura I, Miyazaki Y, Naoe T, Kiyoi H. Ishikawa Y, et al. Among authors: kanamori h. Blood Adv. 2020 Jan 14;4(1):66-75. doi: 10.1182/bloodadvances.2019000709. Blood Adv. 2020. PMID: 31899799 Free PMC article.
Secondary central nervous system lymphoma.
Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: kanamori h. Int J Hematol. 2006 Aug;84(2):128-35. doi: 10.1532/IJH97.06091. Int J Hematol. 2006. PMID: 16926134 Review.
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: kanamori h. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: kanamori h. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. Online ahead of print. Transfus Med Rev. 2018. PMID: 29891441 Free article. Review.
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study.
Kako S, Kimura SI, Wada H, Komiya Y, Nakasone H, Sakurai M, Kato J, Tanaka M, Fujii E, Tachibana T, Yamamoto W, Hagihara M, Watanabe R, Yokota A, Nakano H, Mori T, Nakaseko C, Kanamori H, Okamoto S, Kanda Y. Kako S, et al. Among authors: kanamori h. Leuk Res. 2023 Oct;133:107371. doi: 10.1016/j.leukres.2023.107371. Epub 2023 Aug 7. Leuk Res. 2023. PMID: 37595372
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival.
Nakasone H, Kako S, Tachibana T, Tanaka M, Onizuka M, Takahashi S, Yokota A, Fujiwara SI, Sakura T, Sakaida E, Fujisawa S, Yamazaki R, Gotoh M, Hagihara M, Aotsuka N, Tsukada N, Hatta Y, Shimizu H, Usuki K, Watanabe R, Mori T, Yano S, Kanamori H, Kanda Y. Nakasone H, et al. Among authors: kanamori h. Transplant Cell Ther. 2021 Sep;27(9):800.e1-800.e8. doi: 10.1016/j.jtct.2021.06.020. Epub 2021 Jun 24. Transplant Cell Ther. 2021. PMID: 34171522 Free article.
Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients.
Harada I, Sasaki H, Murakami K, Nishiyama A, Nakabayashi J, Ichino M, Miyazaki T, Kumagai K, Matsumoto K, Hagihara M, Kawase W, Tachibana T, Tanaka M, Saito T, Kanamori H, Fujita H, Fujisawa S, Nakajima H, Tamura T. Harada I, et al. Among authors: kanamori h. Sci Rep. 2021 Sep 10;11(1):18046. doi: 10.1038/s41598-021-97371-8. Sci Rep. 2021. PMID: 34508131 Free PMC article.
Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Ohashi T, Aoki J, Ando T, Ishiyama Y, Ishii Y, Miyashita K, Nakajima Y, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ohashi T, et al. Among authors: kanamori h. Bone Marrow Transplant. 2022 Jul;57(7):1124-1132. doi: 10.1038/s41409-022-01678-7. Epub 2022 May 3. Bone Marrow Transplant. 2022. PMID: 35505096
Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study.
Najima Y, Tachibana T, Takeda Y, Koda Y, Aoyama Y, Toya T, Igarashi A, Tanaka M, Sakaida E, Abe R, Onizuka M, Kobayashi T, Doki N, Ohashi K, Kanamori H, Ishizaki T, Yokota A, Morita S, Okamoto S, Kanda Y. Najima Y, et al. Among authors: kanamori h. Ann Hematol. 2022 Dec;101(12):2719-2729. doi: 10.1007/s00277-022-04981-x. Epub 2022 Sep 23. Ann Hematol. 2022. PMID: 36149461
206 results